Navigation Links
University of Kentucky spinoff licensed to develop Alzheimer's treatment
Date:9/22/2011

LEXINGTON, Ky. (Sept. 21, 2011) -- CoPlex Therapeutics has signed an exclusive global license agreement with Hawthorn Pharmaceuticals to develop and commercialize hawAD14, a preclinical oral small molecule candidate for the treatment of Alzheimer's and other neurodegenerative diseases.

According to a released statement from Hawthorn Pharmaceuticals, a commercial-stage specialty drug company, research indicates hawAD14 significantly decreases production of amyloid beta (Aβ) the major component of senile plaques and alters proteins associated with hyperphosphorylation of tau which is associated with neurofibrillary tangles present in Alzheimer's disease.

"In terms of the discovery's uniqueness, it's one of only a few programs in the world demonstrating multiple protective effects against the predominant pathogenic pathways of Alzhiemer's disease," said Rob Lewis, chief scientific officer at Hawthorn. "We are in the process of completing necessary preclinical studies in order to file an IND (investigational new drug) with the FDA," said Hawthorn CEO Max Draughn.

CoPlex co-founder and CEO John Beran said, "University of Kentucky researchers and CoPlex founding scientists Mark Lovell and Bert Lynn discovered an aberrant protein complex linked to Alzheimer's which gave them a unique approach to begin to interrupt pathogenic mechanisms associated with the disease. They evaluated multiple compounds to see if they could minimize events on the path toward Alzheimer's and the leading candidate was hawAD14."

"The discovery of hawAD14 may be the most promising research of our professional careers," said Mark Lovell, Jack & Linda Gill Professor of Chemistry and research faculty with the UK Sanders-Brown Center on Aging. "We are extremely excited by the potential this compound holds to slow the progression of Alzhiemer's and significantly improve the lives of individuals impacted by this terrible disease." Lovell worked as a graduate
'/>"/>

Contact: Allison Elliott
allison.elliott@uky.edu
University of Kentucky
Source:Eurekalert  

Page: 1 2 3

Related medicine news :

1. University Hospitals Case Medical Center awarded 2011 fellowship awards for pain medicine, epilepsy
2. Wayne State University partners with Toyota on safety research
3. Wayne State University researcher to study spinal muscular atrophy
4. Whole-parasite malaria vaccine shows promise in University of Maryland School of Medicine clinical trial
5. First US patient receives specially processed donor lungs at the University of Maryland
6. University of Houston hosts book symposium on Making War and Minting Christians, Sept. 8
7. FDA clears new IMMY and University of Nevada, Reno life-saving blood test
8. University of Kentucky Sanders-Brown Center on Aging receives $7 million from NIA
9. Major advanced cancer study to be led by Uppsala University
10. Baylor University study finds consequences of co-worker rudeness are far-reaching
11. University Hospitals Neuromuscular Center EMG labs awarded accreditation
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
University of Kentucky spinoff licensed to develop Alzheimer's treatment
(Date:8/28/2014)... Chicago, IL (PRWEB) August 28, 2014 ... Group, Inc., has been re-certified as a federal Patient ... authority of the Agency for Healthcare Research and Quality ... industry-leading patient safety expertise and services following the true ... (PSQIA) of 2005. , ”We are proud and eager ...
(Date:8/28/2014)... THURSDAY, Aug. 28, 2014 (HealthDay News) -- Having greater ... your ability to see distant objects in hazy conditions, ... University of Georgia researchers simulated hazy conditions in order ... levels of yellow pigment (also called macular pigment) in ... of yellow pigment, which represents accumulations of the nutrients ...
(Date:8/28/2014)... (PRWEB) August 28, 2014 GreenRushReview.com, ... sector recently launched a “Video” section located at ... general information on various cannabis companies in video ... find an assortment of news clips, interviews, and ... announcements. A portion of the videos can also ...
(Date:8/28/2014)... On September 10, the Mesothelioma Applied Research ... president and CEO of Aduro BioTech, during a new ... live broadcast. The interview will be led by ... nurse practitioner, Mary Hesdorffer, APRN . , The ... therapy for malignant pleural mesothelioma, known as CRS-207. CRS-207 ...
(Date:8/28/2014)... August 28, 2014 PreDiabetes Centers, the ... of nutritious pizza recipes to help clients and online ... Day. PreDiabetes Concierge Chef Han Ashley developed variations of ... the Company’s website. , The PreDiabetes Centers Roasted Veggie ... pizza dough and features a cheese substitute–ideal for ...
Breaking Medicine News(10 mins):Health News:Clarity PSO Re-lists as a Patient Safety Organization and Continues to Advance Patient Safety 2Health News:Clarity PSO Re-lists as a Patient Safety Organization and Continues to Advance Patient Safety 3Health News:Eye Pigment May Help Vision in Hazy Conditions 2Health News:Emerging Cannabis Industry Website GreenRushReview.com Adds a Featured Video Section to Cover Marijuana Business Sector News 2Health News:Emerging Cannabis Industry Website GreenRushReview.com Adds a Featured Video Section to Cover Marijuana Business Sector News 3Health News:New Clinical Trial: Using the Listeria Virus to Fight Mesothelioma 2Health News:New Clinical Trial: Using the Listeria Virus to Fight Mesothelioma 3Health News:PreDiabetes Centers Concierge Chef Creates Tasty Grilled Veggie Pizza Recipes for Labor Day Party Menu 2Health News:PreDiabetes Centers Concierge Chef Creates Tasty Grilled Veggie Pizza Recipes for Labor Day Party Menu 3
... Partnership to Focus on Energy Conservation and Facility Retrofitting ... July 23 Health Care Without Harm (HCWH) has entered into ... the William J. Clinton Foundation, to develop programs to help hospitals ... of carbon reduction. HCWH will work with CCI to develop ...
... A study led by researchers at the Ohio State ... how late-stage, hormone-independent prostate tumors gain the ability to ... hormone-independent growth marks an advanced and currently incurable stage ... 24, 2009, issue of the journal Cell , ...
... release is available in German . , The ... often overestimated. According to the German Institute for Quality and Efficiency ... travellers. When people wear a cast or splint after a sports ... have an increased risk of deep vein thrombosis in their leg ...
... , SOUTH SAN FRANCISCO, Calif., July 23 ... Company plans to host a conference call on Thursday, July 23, 2009 ... management team and the principal investigator of the trial will discuss results ... arthritis, the Company,s plans for further development and related matters. , ...
... ... heart function without need for cardiac stem cells , ... (Vocus) July 16, 2009 -- Injured heart tissue normally can,t regrow, ... heart tissue after a heart attack, in patients with heart failure, or in children with ...
... how ,plastic, these non-embryonic cells can be, experts say ... may be named "Tiny," but what it represents in ... According to Chinese researchers, the birth of Tiny (and ... Healthy, fertile animals grown using so-called pluripotent stem cells ...
Cached Medicine News:Health News:Health Care Without Harm Partners With Clinton Climate Initiative to Help Hospitals and Healthcare Facilities Reduce Environmental Impact 2Health News:Health Care Without Harm Partners With Clinton Climate Initiative to Help Hospitals and Healthcare Facilities Reduce Environmental Impact 3Health News:Scientists discover key event in prostate cancer progression 2Health News:The risk of developing deep vein thrombosis during a flight is often overestimated 2Health News:Rigel to Host Conference Call to Discuss Results of Its Phase 2b TASKi3 Clinical Trial of R788 in Rheumatoid Arthritis 2Health News:Study in this Week's Issue of Cell Finds Injected Growth Factor Spurs Heart Regeneration 2Health News:Study in this Week's Issue of Cell Finds Injected Growth Factor Spurs Heart Regeneration 3Health News:Scientists Use Adult Stem Cells to Create Healthy Mice 2Health News:Scientists Use Adult Stem Cells to Create Healthy Mice 3
(Date:8/28/2014)... , Aug. 28, 2014 GenSpera, Inc. ... the treatment of cancer, announces the recent publication of ... Steroids . The recent article co-authored ... the evolution and development of GenSpera,s prodrug technology platform that ... thapsigargin (from the plant Thapsia garganica ) directly ...
(Date:8/28/2014)... MONROVIA, Calif. , Aug. 28, 2014  STAAR Surgical ... and marketer of implantable lenses and delivery systems for the ... 2014 Health Care Conference at the New York Palace Hotel ... Barry Caldwell , President and CEO will ... financial results, and operational developments and be joined by ...
(Date:8/28/2014)... -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL ... trials evaluating the use of collagenase clostridium histolyticum (CCH) for ... with a palpable cord will be presented at the upcoming ... Surgery of the Hand (ASSH) being held in ... (CCH) is a biologic approved in the U.S., EU, ...
Breaking Medicine Technology:GenSpera Media Advisory; "Targeting thapsigargin towards tumors" Published in Steroids 2GenSpera Media Advisory; "Targeting thapsigargin towards tumors" Published in Steroids 3STAAR Surgical To Present At The Baird 2014 Health Care Conference 2Auxilium Pharmaceuticals, Inc. To Present CCH Data For Concurrent Treatment Of Multiple Dupuytren's Cords At ASSH Annual Meeting 2Auxilium Pharmaceuticals, Inc. To Present CCH Data For Concurrent Treatment Of Multiple Dupuytren's Cords At ASSH Annual Meeting 3Auxilium Pharmaceuticals, Inc. To Present CCH Data For Concurrent Treatment Of Multiple Dupuytren's Cords At ASSH Annual Meeting 4Auxilium Pharmaceuticals, Inc. To Present CCH Data For Concurrent Treatment Of Multiple Dupuytren's Cords At ASSH Annual Meeting 5Auxilium Pharmaceuticals, Inc. To Present CCH Data For Concurrent Treatment Of Multiple Dupuytren's Cords At ASSH Annual Meeting 6
... Stabilization with the Orthofix Pelvic Fixator is ... into the pelvis, and a fixator assembly ... by a connector unit. A supplementary link ... in iliac crest applications. With this new ...
The Pinless Fixator can be applied quickly and easily in the OR or ER to stabilize the fracture and soft tissues without invading the medullary canal, minimizing the risk of infection associated with...
The Adjustable Large Fixator is a one-piece fixator with a radiolucent body. It has a multifunctional design pivoting pin clamp for use in ankle or tibial plateau fractures....
The Small External Fixator has straight or angled frames, independent pin placement, and combines easily with Large and Medium External Fixator frames....
Medicine Products: